CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 165 enrolled
Drug / intervention
Vessel Closure (StarClose™)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00736086
NCT00736086N/ACompleted

A Post-Market, Prospective, Multi-Center, Study to Evaluate Safety and Efficacy of the StarClose™ Vascular Closure System in Patients Who Are Ambulated Early Post-Diagnostic Catheterization

Abbott Medical Devices·observational·Posted Aug 15, 2008·Updated Aug 15, 2008

In Brief

An observational study evaluating Vessel Closure (StarClose™) for Peripheral Vascular Disease and Cardiovascular Disease. Completed, enrolled 165 participants across 11 sites.

Detailed Summary

To evaluate early ambulation in patients who receive the StarClose™ VCS post-percutaneous diagnostic procedure.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 15, 2008
Enrollment StartMar 1, 2006
Primary CompletionNov 1, 2006
Study CompletionDec 1, 2006
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 17.9 years ago

Interventions

Vessel Closure (StarClose™)device